(Q72708138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca2+ antagonistic activity of tinctormine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

2 references

(4S)-3,4,5-trihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohexa-2,5-dien-1-one

1 reference

inferred from

reverse claim

Hydroxysafflor Yellow A

1 reference

1 reference

(4R)-3,4,5-trihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-[(2R,3R,4R,5S,6S)-3,5,6-trihydroxy-4-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohexa-2,5-dien-1-one

1 reference

1 reference

1 reference

(4S)-5-{[(2Z,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-ylidene](hydroxy)methyl}-3,4-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-[(2R,3R,4R,5S,6S)-3,5,6-trihydroxy-4-(hydroxymethyl)oxan-2-yl]cyclohexa-2,5-dien-1-one

1 reference

inferred from

reverse claim

5-{[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-ylidene](hydroxy)methyl}-3,4-dihydroxy-2-[3-(4-hydroxyphenyl)prop-2-enoyl]-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohexa-2,5-dien-1-one

1 reference

1 reference

(2E)-5-[(Z)-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-ylidene]-hydroxymethyl]-6-hydroxy-2-[1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-6-[(2R,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione

1 reference

M R Meselhy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Kadota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Y Momose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

N Hatakeyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A Kusai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Hattori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

T Namba

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

Chemical & Pharmaceutical Bulletin

28 October 2019

language of work or name

English

1 reference

inferred from

publication date

1993

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/41/10/41_10_1796/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.41.1796?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1796-1802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.41.1796?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Constituents of the roots of Boerhaavia diffusa L. III. Identification of Ca2+ channel antagonistic compound from the methanol extract

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.39.1551

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

Tinctormine, a novel Ca2+ antagonist N-containing quinochalcone C-glycoside from Carthamus tinctorius L

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.40.3355

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

Apamin, a highly specific Ca2+ blocking agent in heart muscle.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

The effect of two different calcium antagonists on the glomerular haemodynamics in the dog.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.41.1796

Identifiers

DOI

10.1248/CPB.41.1796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8281577%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference